William J. McClellan
AbbVie (United States)(US)
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Cell death mechanisms and regulation, Protease and Inhibitor Mechanisms, Analytical Chemistry and Chromatography, Peptidase Inhibition and Analysis
Most-Cited Works
- → Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL(2007)294 cited
- → A Small-Molecule Inhibitor of Bcl-XL Potentiates the Activity of Cytotoxic Drugs In vitro and In vivo(2006)146 cited
- → Discovery and Structure−Activity Relationship of Antagonists of B-Cell Lymphoma 2 Family Proteins with Chemopotentiation Activity in Vitro and in Vivo(2006)130 cited
- → Identification of Novel Binding Interactions in the Development of Potent, Selective 2-Naphthamidine Inhibitors of Urokinase. Synthesis, Structural Analysis, and SAR of N-Phenyl Amide 6-Substitution(2003)66 cited
- → Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors(2017)64 cited
- → Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinases(2011)49 cited
- → Reduction of nanoparticle exposure to welding aerosols by modification of the ventilation system in a workplace(2006)47 cited
- → Conformationally defined adrenergic agents. 1. Design and synthesis of novel .alpha.2-selective adrenergic agents: electrostatic repulsion based conformational prototypes(1985)37 cited
- → A simple, high-yielding method for the methylenation of catechols(1991)33 cited
- → Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors(2004)28 cited